Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DEB-TACE”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableStudy completedNCT03317483
What this trial is testing

DEB-TACE Treatment in 367 Liver Cancer Patients

Who this might be right for
Liver Cancer
Zhejiang Cancer Hospital 367
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Not applicableNot Yet RecruitingNCT06823050
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 59
Not applicableUnknownNCT05788835
What this trial is testing

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

Who this might be right for
HCC
Xuhua Duan 220
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Not applicableEnded earlyNCT02967523
What this trial is testing

Surefire Precision Infusion System Registry

Who this might be right for
Hepatocellular Carcinoma
Surefire Medical, Inc. 111
Not applicableUnknownNCT04967482
What this trial is testing

DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 216
Large-scale testing (Phase 3)UnknownNCT04229355
What this trial is testing

DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 90
Not applicableUnknownNCT05103007
What this trial is testing

PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Testing effectiveness (Phase 2)UnknownNCT04479527
What this trial is testing

Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 34
Large-scale testing (Phase 3)Looking for participantsNCT07322848
What this trial is testing

DEB-TACE vs cTACE in HCC After TIPS

Who this might be right for
Hepatocellular Carcinoma (HCC)TACETIPS+2 more
First Affiliated Hospital, Sun Yat-Sen University 206
Not applicableUnknownNCT04653701
What this trial is testing

Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Juan José Ciampi Dopazo 30
Very early researchUnknownNCT05093920
What this trial is testing

Role of DEB-TACE Versus c-TACE in Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Sohag University 30
Post-approval studies (Phase 4)Looking for participantsNCT06353126
What this trial is testing

DEB-TACE Prior to Liver Transplantation in the Treatment of HCC

Who this might be right for
Liver Cancer
RenJi Hospital 40
Not applicableUnknownNCT05025592
What this trial is testing

CTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

Who this might be right for
HCCTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
Peking University Cancer Hospital & Institute 60
Not applicableWithdrawnNCT03452553
What this trial is testing

Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin

Who this might be right for
Hepatocellular Carcinoma (HCC)
Boston Scientific Corporation
Testing effectiveness (Phase 2)Study completedNCT03638141
What this trial is testing

CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab

Who this might be right for
Intermediate Stage of Hepatocellular CarcinomaHepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Very early researchStudy completedNCT03143270
What this trial is testing

Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06904183
What this trial is testing

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 320
Next Page